This 30-minute live broadcast focuses on highlights from the ACR Convergence 2020 conference. You will learn about new evidence regarding psoriatic arthritis (PsA) in the context of COVID-19 presented in a clinical discussion with the prominent rheumatology expert in this clinical area. This broadcast features the latest data synthesized to provide information most relevant to clinical practice. Topics include efficacy and safety of existing and novel targeted therapies for PsA and strategies for minimizing the risk of infections and adverse events for patients with PsA at the time of the COVID-19 pandemic.
APPROVED ACR EDUCATION PARTNER: This activity is included in the ACR’s Education Partner program. Independent reporting and the viewpoints expressed are those of Forefront Collaborative and its affiliates and do not represent the ACR.